Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
e fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
Showing 141 - 160 results of 25,230 for search '(( e fold decrease ) OR ( 5 ((((ng decrease) OR (mean decrease))) OR (nn decrease)) ))', query time: 0.86s Refine Results
  1. 141
    Infectivity of HIV-1 particles decreases upon treatment with MEK inhibitor.

    Infectivity of HIV-1 particles decreases upon treatment with MEK inhibitor. by Sheila Mansouri (324272)

    Published 2013
    Save to List
    Saved in:
  2. 142
    TSA treatment significantly decreases total cholesterol content in neuroblastoma cells.

    TSA treatment significantly decreases total cholesterol content in neuroblastoma cells. by Maria João Nunes (160499)

    Published 2013
    Save to List
    Saved in:
  3. 143
    Increased miR200c decreases FAP-1 expression.

    Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)

    Published 2013
    Save to List
    Saved in:
  4. 144
    TREM1 inhibition decreases HIV mediated inflammatory cytokine production.

    TREM1 inhibition decreases HIV mediated inflammatory cytokine production. by Jinhee Hyun (6900683)

    Published 2019
    Save to List
    Saved in:
  5. 145
    Inhibition of ERK 1/2 decreases GM-CSF- and IL-3-responsive Eo/B CFU, but not IL-5-responsive colonies.

    Inhibition of ERK 1/2 decreases GM-CSF- and IL-3-responsive Eo/B CFU, but not IL-5-responsive colonies. by Pia Reece (589971)

    Published 2014
    Save to List
    Saved in:
  6. 146
    HPx1 expression is controlled by dietary heme and the E75 transcription factor.

    HPx1 expression is controlled by dietary heme and the E75 transcription factor. by Octavio A. C. Talyuli (4285141)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  7. 147
    Mitochondrial respiration of HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG.

    Mitochondrial respiration of HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. by Patrick Mordel (17020879)

    Published 2023
    Save to List
    Saved in:
  8. 148
    Measurement of the MMP in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG.

    Measurement of the MMP in HL-1 cells exposed for 12 or 72h to LG, NG, HG or IHG. by Patrick Mordel (17020879)

    Published 2023
    Save to List
    Saved in:
  9. 149
    CCS1477 decreases phosphorylated ATR (pATR) and phosphorylated ATM (pATM).

    CCS1477 decreases phosphorylated ATR (pATR) and phosphorylated ATM (pATM). by Changkun Hu (12077989)

    Published 2022
    Save to List
    Saved in:
  10. 150
    The m<sup>6</sup>A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells.

    The m<sup>6</sup>A peak of 3’UTR of TLR4 mRNA decreases significantly in METTL14-knockdown PK-15 cells. by Jing Chen (4762)

    Published 2024
    Save to List
    Saved in:
  11. 151
    Fig 7 -

    Fig 7 - by Henning Carstens (13132801)

    Published 2022
    Save to List
    Saved in:
  12. 152
    Combining metformin and esomeprazole additively decreases sFlt-1 secretion and expression, and increases VEGF expression in placental and endothelial cells.

    Combining metformin and esomeprazole additively decreases sFlt-1 secretion and expression, and increases VEGF expression in placental and endothelial cells. by Tu’uhevaha J. Kaitu’u-Lino (317587)

    Published 2018
    Save to List
    Saved in:
  13. 153
    Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups.

    Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 154
    Mean Decrease in Margin (MDM) variable importance.

    Mean Decrease in Margin (MDM) variable importance. by Yuliya V. Karpievitch (259460)

    Published 2009
    Save to List
    Saved in:
  15. 155
    Baseline clinical profile of hospitalized COVID-19 patients with low and high renalase.

    Baseline clinical profile of hospitalized COVID-19 patients with low and high renalase. by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  16. 156
    Cox hazard regression model of renalase and primary composite outcome.

    Cox hazard regression model of renalase and primary composite outcome. by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  17. 157
    Flow chart of study patients from all COVID-19 admissions to the institution from March to July 2020.

    Flow chart of study patients from all COVID-19 admissions to the institution from March to July 2020. by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  18. 158
    Time adjusted survival curves for high vs. low renalase among patients with COVID-19 disease (using first quartile as cutoff).

    Time adjusted survival curves for high vs. low renalase among patients with COVID-19 disease (using first quartile as cutoff). by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  19. 159
    Time-adjusted survival curve for IL-6 and renalase among patients with COVID-19 disease (A) For composite outcome<sup>a</sup>: High renalase + High IL-6; High renalase + Low IL-6; Low renalase + High IL-6; Low renalase + Low IL-6 and (B) For Mortality: High renalase + High IL-6; High renalase + Low IL-6; Low renalase + High IL-6; Low renalase + Low IL-6.

    Time-adjusted survival curve for IL-6 and renalase among patients with COVID-19 disease (A) For composite outcome<sup>a</sup>: High renalase + High IL-6; High renalase + Low IL-6;... by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  20. 160
    Evaluation of the PCSK9 vaccine (V2 vaccine) in male <i>ApoE-deficient mice</i> (N = 5–7).

    Evaluation of the PCSK9 vaccine (V2 vaccine) in male <i>ApoE-deficient mice</i> (N = 5–7). by Ryo Kawakami (4849549)

    Published 2018
    Save to List
    Saved in:

Search Tools: